{"name": "Foldrx Pharmaceuticals",
 "permalink": "foldrx-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/foldrx-pharmaceuticals",
 "homepage_url": "http://www.foldrx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2003,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@foldrx.com",
 "phone_number": "617-252-5500",
 "description": "",
 "created_at": "Wed Jun 16 14:01:56 UTC 2010",
 "updated_at": "Wed Jun 16 14:01:55 UTC 2010",
 "overview": "\u003Cp\u003EFoldRx Pharmaceuticals, Inc. engages in the discovery and development of disease modifying drug therapies for diseases of protein misfolding and amyloidosis. The company\u00d0\u00a2s pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, transthyretin-associated amyloidoses with polyneuropathy and TTR-associated amyloidoses with cardiomyopathy, and a discovery program in Parkinson\u0026#8217;s disease and cystic fibrosis. FoldRx Pharmaceuticals, Inc. was founded in 2003 and is based in Cambridge, Massachusetts.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Richard",
      "last_name": "Labaudini\u00c3\u00a8re",
      "permalink": "richard-labaudinire",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$29M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/foldrx-banks-29m-neurodegenerative-drug-application/2010-06-15?utm_medium=rss\u0026utm_source=rss",
    "source_description": "FoldRx banks $29M for neurodegenerative drug application",
    "raised_amount": 29000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 6,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novo Ventures",
         "permalink": "novo-ventures",
         "image":
          {"available_sizes":
            [[[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-150x150.jpg"],
             [[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-250x250.jpg"],
             [[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Morgenthaler Ventures",
         "permalink": "morgenthaler-ventures",
         "image":
          {"available_sizes":
            [[[150,
               73],
              "assets/images/resized/0001/2347/12347v1-max-150x150.png"],
             [[221,
               108],
              "assets/images/resized/0001/2347/12347v1-max-250x250.png"],
             [[221,
               108],
              "assets/images/resized/0001/2347/12347v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCare Ventures",
         "permalink": "healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9268/49268v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0004/9268/49268v1-max-250x250.jpg"],
             [[290,
               40],
              "assets/images/resized/0004/9268/49268v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Fidelity Biosciences",
         "permalink": "fidelity-biosciences-2",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0005/0044/50044v1-max-150x150.png"],
             [[233,
               79],
              "assets/images/resized/0005/0044/50044v1-max-250x250.png"],
             [[233,
               79],
              "assets/images/resized/0005/0044/50044v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "TPG Biotechnology Partners",
         "permalink": "tpg-biotechnology-partners",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Funds",
         "permalink": "novartis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               14],
              "assets/images/resized/0004/4137/44137v1-max-150x150.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-250x250.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": null,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.foldrx.com/e4df4c77-5824-4ea5-94b7-aede5d74e4f5/news-press-detail.htm",
   "source_description": "Pfizer To Acquire FoldRx Pharmaceuticals",
   "acquired_year": 2010,
   "acquired_month": 9,
   "acquired_day": 1,
   "acquiring_company":
    {"name": "Pfizer",
     "permalink": "pfizer",
     "image":
      {"available_sizes":
        [[[82,
           55],
          "assets/images/resized/0005/9046/59046v1-max-150x150.png"],
         [[82,
           55],
          "assets/images/resized/0005/9046/59046v1-max-250x250.png"],
         [[82,
           55],
          "assets/images/resized/0005/9046/59046v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "100 Acorn Park Drive",
    "address2": "5th Floor",
    "zip_code": "02140",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}